Ozelle demonstrates O-Cyte 1 automated cell imaging analyzer at MEDICA

Ozelle is demonstrating O-Cyte 1 at MEDICA 2026, an automated hematology analyzer that combines routine complete blood count testing with high-resolution cell imaging. The company says the system makes captured cell images available alongside CBC results for further morphology review.
- O-Cyte 1 combines routine CBC testing with high-resolution cell imaging.
- Its AI × CBM technology provides AI-assisted morphology analysis.
- The analyzer supports 25-tube batches and processes up to 60 tests per hour alone.
- Six connected units can process up to 360 tests per hour.
- Live demonstrations continue through November 19 at MEDICA 2026.
Cell images alongside routine blood counts
O-Cyte 1 uses Ozelle’s AI × CBM, or Complete Blood Morphology, technology to combine cell imaging with AI-assisted morphology analysis. The analyzer integrates this capability with 7-part white blood cell differentiation.
When an automated CBC test identifies an unusual finding, laboratory professionals can review the associated cell images when additional morphology assessment is needed. This gives laboratories visual information linked to routine test results, according to Ozelle’s announcement.
Jie Du, Ozelle’s co-founder and head of research and development, said: “We wanted to make cell morphology part of routine CBC testing while keeping laboratory workflows efficient.” Du added: “That meant designing the entire system with sample handling, image review and maintenance in mind.”
Designed for laboratory workflows and scaling
The analyzer supports 25-tube batch loading, automated barcode identification and mixing, closed-tube sampling, and STAT priority for urgent tests. A standalone analyzer processes up to 60 tests per hour, while six connected units can process up to 360 tests per hour, according to Ozelle.
These features are intended to let laboratories add capacity as workloads grow while keeping the additional imaging information within existing testing processes. The company positions the system for laboratories that need routine hematology testing with access to cell images when further review is required.
Replaceable components target maintenance needs
Ozelle says O-Cyte 1 integrates key fluid-contact components into a replaceable reagent kit. The design is intended to help reduce cleaning inside the instrument compared with conventional analyzers that use reusable internal fluid paths and require regular cleaning.
Built-in self-checks and replaceable modules are designed to support troubleshooting and servicing, including after-sales support for distributors. The maintenance approach is also relevant to clinics and decentralized testing sites, where Ozelle says broader testing, limited space and reduced upkeep are priorities.
Ozelle presents wider human and veterinary portfolio
O-Cyte 1 is part of Ozelle’s compact EHBT analyzer series for human care. The series covers hematology, cell imaging, immunoassay and dry biochemistry. Ozelle’s EHVT veterinary series offers hematology, digital cell morphology, immunoassay, biochemistry, urine and fecal testing.
The company says both product lines emphasize reliable performance, straightforward operation and minimal routine maintenance. Live demonstrations of the analyzers continue through November 19 at Hall 1, Booth D63, at Messe Düsseldorf, where visitors can observe the systems and discuss clinical applications and distribution opportunities.


